ID

32478

Beschreibung

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01007526

Link

https://clinicaltrials.gov/show/NCT01007526

Stichworte

Versionen (1)
  1. 02.11.18 02.11.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

2. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Stage I/II Extranodal NK/T-cell Lymphoma NCT01007526

Englisch

Eligibility Stage I/II Extranodal NK/T-cell Lymphoma NCT01007526

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients were required to have a biopsy-proven diagnosis of nasal enktl
Beschreibung

Nasal Type Extranodal NK/T-Cell Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0392788
at least 18 years old
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ann arbor stage ie or iie
Beschreibung

Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1]
C0432516
measurable disease
Beschreibung

Measurable Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status of 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy greater than 12 weeks
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
adequate hematologic (hemoglobin > 9.0 g/dl, absolute neutrophil count > 1,500/ul and platelets > 100,000/ul)
Beschreibung

Hematologic function | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
renal (serum creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min)
Beschreibung

Renal function | Creatinine measurement, serum | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C0373595
hepatic (total bilirubin < 2 times of upper limit of normal and aspartate transferase < 3 times of upper limit of normal) function
Beschreibung

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
diagnosis of enktl is based on the presence of histological features and immunophenotypes compatible with enktl (e.g., cytoplasmic cd3+, cd20-, cd56+, positive for cytotoxic molecules, positive for ebv by in situ hybridization).
Beschreibung

Feature Histologic Consistent with Extranodal NK-T-Cell Lymphoma | Immunophenotype Histologic Consistent with Extranodal NK-T-Cell Lymphoma | Cytoplasmic CD3 Positive In Situ Hybridization | Cytoplasmic CD20 Negative In Situ Hybridization | Cytoplasmic Cell positive for CD56 antigen In Situ Hybridization | Molecule Cytotoxic Positive In Situ Hybridization | EBV Positive In Situ Hybridization

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1521970
UMLS CUI [1,2]
C0205462
UMLS CUI [1,3]
C0332290
UMLS CUI [1,4]
C1955906
UMLS CUI [2,1]
C0079611
UMLS CUI [2,2]
C0205462
UMLS CUI [2,3]
C0332290
UMLS CUI [2,4]
C1955906
UMLS CUI [3,1]
C0521449
UMLS CUI [3,2]
C4329510
UMLS CUI [3,3]
C0162788
UMLS CUI [4,1]
C0521449
UMLS CUI [4,2]
C4527200
UMLS CUI [4,3]
C0162788
UMLS CUI [5,1]
C0521449
UMLS CUI [5,2]
C0882903
UMLS CUI [5,3]
C0162788
UMLS CUI [6,1]
C0567416
UMLS CUI [6,2]
C1511636
UMLS CUI [6,3]
C1514241
UMLS CUI [6,4]
C0162788
UMLS CUI [7,1]
C4329796
UMLS CUI [7,2]
C0162788
informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior or concomitant malignant tumors
Beschreibung

Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
any coexisting medical problems of sufficient severity to prevent full compliance with the study protocol.
Beschreibung

Comorbidity Severe Preventing Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C1292733
UMLS CUI [1,4]
C0525058
enktl with non-nasal sites such as skin or gastrointestinal tract was excluded even if it is localized.
Beschreibung

Extranodal NK-T-Cell Lymphoma Skin | Extranodal NK-T-Cell Lymphoma Gastrointestinal tract

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1955906
UMLS CUI [1,2]
C1123023
UMLS CUI [2,1]
C1955906
UMLS CUI [2,2]
C0017189
other subtypes of non-hodgkin lymphoma (nhl), including myeloid/nk cell precursor acute leukemia, blastic nk cell lymphoma/precursor nk cell lymphoblastic leukemia, aggressive nk cell leukemia, and peripheral t cell lymphoma, unspecified, were excluded.
Beschreibung

Non-Hodgkin Lymphoma Subtype | Leukemia, Myelocytic, Acute | Natural Killer Cell Lymphoblastic Leukemia/Lymphoma | Aggressive natural killer-cell leukemia | Peripheral T-Cell Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C0449560
UMLS CUI [2]
C0023467
UMLS CUI [3]
C2826059
UMLS CUI [4]
C1292777
UMLS CUI [5]
C0079774
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Stage I/II Extranodal NK/T-cell Lymphoma NCT01007526

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Nasal Type Extranodal NK/T-Cell Lymphoma
Item
patients were required to have a biopsy-proven diagnosis of nasal enktl
boolean
C0392788 (UMLS CUI [1])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage ie or iie
boolean
C0432516 (UMLS CUI [1])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy greater than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Hematologic function | Hemoglobin measurement | Absolute neutrophil count | Platelet Count measurement
Item
adequate hematologic (hemoglobin > 9.0 g/dl, absolute neutrophil count > 1,500/ul and platelets > 100,000/ul)
boolean
C0221130 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
Renal function | Creatinine measurement, serum | Creatinine clearance measurement
Item
renal (serum creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement
Item
hepatic (total bilirubin < 2 times of upper limit of normal and aspartate transferase < 3 times of upper limit of normal) function
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Feature Histologic Consistent with Extranodal NK-T-Cell Lymphoma | Immunophenotype Histologic Consistent with Extranodal NK-T-Cell Lymphoma | Cytoplasmic CD3 Positive In Situ Hybridization | Cytoplasmic CD20 Negative In Situ Hybridization | Cytoplasmic Cell positive for CD56 antigen In Situ Hybridization | Molecule Cytotoxic Positive In Situ Hybridization | EBV Positive In Situ Hybridization
Item
diagnosis of enktl is based on the presence of histological features and immunophenotypes compatible with enktl (e.g., cytoplasmic cd3+, cd20-, cd56+, positive for cytotoxic molecules, positive for ebv by in situ hybridization).
boolean
C1521970 (UMLS CUI [1,1])
C0205462 (UMLS CUI [1,2])
C0332290 (UMLS CUI [1,3])
C1955906 (UMLS CUI [1,4])
C0079611 (UMLS CUI [2,1])
C0205462 (UMLS CUI [2,2])
C0332290 (UMLS CUI [2,3])
C1955906 (UMLS CUI [2,4])
C0521449 (UMLS CUI [3,1])
C4329510 (UMLS CUI [3,2])
C0162788 (UMLS CUI [3,3])
C0521449 (UMLS CUI [4,1])
C4527200 (UMLS CUI [4,2])
C0162788 (UMLS CUI [4,3])
C0521449 (UMLS CUI [5,1])
C0882903 (UMLS CUI [5,2])
C0162788 (UMLS CUI [5,3])
C0567416 (UMLS CUI [6,1])
C1511636 (UMLS CUI [6,2])
C1514241 (UMLS CUI [6,3])
C0162788 (UMLS CUI [6,4])
C4329796 (UMLS CUI [7,1])
C0162788 (UMLS CUI [7,2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
prior or concomitant malignant tumors
boolean
C0006826 (UMLS CUI [1])
Comorbidity Severe Preventing Protocol Compliance
Item
any coexisting medical problems of sufficient severity to prevent full compliance with the study protocol.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1292733 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
Extranodal NK-T-Cell Lymphoma Skin | Extranodal NK-T-Cell Lymphoma Gastrointestinal tract
Item
enktl with non-nasal sites such as skin or gastrointestinal tract was excluded even if it is localized.
boolean
C1955906 (UMLS CUI [1,1])
C1123023 (UMLS CUI [1,2])
C1955906 (UMLS CUI [2,1])
C0017189 (UMLS CUI [2,2])
Non-Hodgkin Lymphoma Subtype | Leukemia, Myelocytic, Acute | Natural Killer Cell Lymphoblastic Leukemia/Lymphoma | Aggressive natural killer-cell leukemia | Peripheral T-Cell Lymphoma
Item
other subtypes of non-hodgkin lymphoma (nhl), including myeloid/nk cell precursor acute leukemia, blastic nk cell lymphoma/precursor nk cell lymphoblastic leukemia, aggressive nk cell leukemia, and peripheral t cell lymphoma, unspecified, were excluded.
boolean
C0024305 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2])
C2826059 (UMLS CUI [3])
C1292777 (UMLS CUI [4])
C0079774 (UMLS CUI [5])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video